Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC).

Lelli, G; Melotti, B; Pannuti, F; Rossi, A P; Maver, P; Mannini, D; Corrado, G; Severini, G; Bercovich, E; Beghelli, R

Lelli, G; Melotti, B; Pannuti, F; Rossi, A P; Maver, P; Mannini, D; Corrado, G; Severini, G; Bercovich, E; Beghelli, R.

Affiliation

Lelli G; Oncology Dept., S. Orsola-Malpighi Hosp., Bologna, Italy.

J Chemother ; 4(4): 239-43, 1992 Aug.

Article in En | MEDLINE | ID: mdl-1403081

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Transitional Cell/drug therapy; Urinary Bladder Neoplasms/drug therapy; Aged; Cisplatin/administration & dosage; Creatinine/blood; Creatinine/urine; Drug Administration Schedule; Epirubicin/administration & dosage; Female; Humans; Male; Metabolic Clearance Rate/drug effects; Methotrexate/administration & dosage; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 1992 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links